Biomea Fusion, Inc. (BMEA)
NASDAQ: BMEA · Real-Time Price · USD
2.670
+0.520 (24.19%)
At close: Oct 6, 2025, 4:00 PM EDT
2.430
-0.240 (-8.99%)
Pre-market: Oct 7, 2025, 4:32 AM EDT
Biomea Fusion Market Cap
Biomea Fusion has a market cap or net worth of $158.89 million as of October 6, 2025. Its market cap has decreased by -49.51% in one year.
Market Cap
158.89M
Enterprise Value
109.72M
1-Year Change
-49.51%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since the IPO on April 16, 2021, Biomea Fusion's market cap has decreased from $489.05M to $158.89M, a decrease of -67.51%. That is a compound annual growth rate of -22.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 127.94M | -9.01% |
| Dec 31, 2024 | 140.61M | -72.88% |
| Dec 29, 2023 | 518.45M | 109.21% |
| Dec 30, 2022 | 247.81M | 14.52% |
| Dec 31, 2021 | 216.38M | -55.75% |
| Apr 16, 2021 | 489.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 760.61B |
| Johnson & Johnson | 455.73B |
| AbbVie | 407.99B |
| UnitedHealth Group | 327.56B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.20B |